These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 34788308)

  • 21. Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey.
    Lee M; You M
    J Med Internet Res; 2022 Jan; 24(1):e32329. PubMed ID: 34870605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour.
    Breslin G; Dempster M; Berry E; Cavanagh M; Armstrong NC
    PLoS One; 2021; 16(11):e0259381. PubMed ID: 34788330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and influenza vaccine-hesitancy subgroups.
    Mäki KO; Karlsson LC; Kaakinen JK; Schmid P; Lewandowsky S; Antfolk J; Soveri A
    PLoS One; 2024; 19(7):e0308159. PubMed ID: 39078836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
    Sasse K; Mahabir R; Gkountouna O; Crooks A; Croitoru A
    PLoS One; 2024; 19(6):e0301488. PubMed ID: 38843170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding national trends in COVID-19 vaccine hesitancy in Canada: results from five sequential cross-sectional representative surveys spanning April 2020-March 2021.
    Lavoie K; Gosselin-Boucher V; Stojanovic J; Gupta S; Gagné M; Joyal-Desmarais K; Séguin K; Gorin SS; Ribeiro P; Voisard B; Vallis M; Corace K; Presseau J; Bacon S;
    BMJ Open; 2022 Apr; 12(4):e059411. PubMed ID: 35383087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom.
    Nguyen LH; Joshi AD; Drew DA; Merino J; Ma W; Lo CH; Kwon S; Wang K; Graham MS; Polidori L; Menni C; Sudre CH; Anyane-Yeboa A; Astley CM; Warner ET; Hu CY; Selvachandran S; Davies R; Nash D; Franks PW; Wolf J; Ourselin S; Steves CJ; Spector TD; Chan AT;
    Nat Commun; 2022 Feb; 13(1):636. PubMed ID: 35105869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and Correlates of SARS-CoV-2 Vaccine Uptake and Hesitancy Among People With HIV Across the United States.
    Spinelli MA; Johnson MO; Lisha NE; Jain JP; Moreira CV; Glidden DV; Burkholder GA; Crane HM; Jacobson JM; Cachay ER; Mayer KH; Napravnik S; Moore RD; Gandhi M; Christopoulos KA
    J Acquir Immune Defic Syndr; 2024 Sep; 97(1):13-18. PubMed ID: 39116328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.
    Levin J; Bradshaw M
    BMC Public Health; 2022 May; 22(1):1047. PubMed ID: 35614396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining the influence of community leaders and other community actors on immunisation practices in Australia: A national cross-sectional study.
    McDermid P; Abdi I; Mustafa K; Blazek K; Harris-Roxas B; Jackson CJ; Seale H
    Vaccine; 2024 Jun; 42(17):3647-3654. PubMed ID: 38704260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Willingness to get vaccinated initially and yearly against COVID-19 and its association with vaccine hesitancy, vaccine knowledge and psychological well-being: a cross-sectional study in UK adults.
    Kale D; Shoesmith E; Herbec A; Shahab L
    BMJ Open; 2024 Jul; 14(7):e080778. PubMed ID: 38969372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring COVID-19 vaccine hesitancy among college students with disabilities: Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy.
    Umucu E; Lee B; Bezyak J
    J Am Coll Health; 2024; 72(4):1208-1214. PubMed ID: 35613333
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    Sheikh NS; Touseef M; Sultan R; Cheema KH; Cheema SS; Sarwar A; Siddique HZ
    PLoS One; 2023; 18(8):e0289678. PubMed ID: 37585457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
    Gallant AJ; Nicholls LAB; Rasmussen S; Cogan N; Young D; Williams L
    PLoS One; 2021; 16(12):e0261844. PubMed ID: 34941951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
    Steinmetz L
    BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021.
    King WC; Rubinstein M; Reinhart A; Mejia R
    PLoS One; 2021; 16(12):e0260731. PubMed ID: 34932583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing COVID-19 vaccine uptake among Latinos: A cross-sectional study.
    Smith DG; Smith CD; DeLeon JA; Sandoz JL; Ochoa CO; Pearson MP; Macena RHM
    PLoS One; 2024; 19(7):e0302332. PubMed ID: 38968176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study.
    Huang Y; Zhang L; Fu J; Wu Y; Wang H; Xiao W; Xin Y; Dai Z; Si M; Chen X; Jia M; Leng Z; Cui D; Su X
    JMIR Public Health Surveill; 2023 Jul; 9():e42958. PubMed ID: 37247615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trusted Information Sources About the COVID-19 Vaccine Vary in Underserved Communities.
    Benson BR; Rahman SA; Bleasdale J; Win S; Townsend-Kensinger K; Cole M; Jalal K; Yu J; Morse GD; Mohler JL; Ward RL
    J Community Health; 2024 Aug; 49(4):598-605. PubMed ID: 38300477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.